, Tracking Stock Market Picks
Enter Symbol:
Qiagen N.v. (QGEN) [hlAlert]

down 31.00 %

Qiagen N.v. (QGEN) downgraded to Underweight by HSBC Securities

Posted on: Thursday,  Oct 11, 2012  8:25 AM ET by HSBC Securities

HSBC Securities rated Underweight Qiagen N.v. (NASDAQ: QGEN) on 10/11/2012, when the stock price was $18.49. Since
then, Qiagen N.v. has gained 44.94% as of 01/15/2016's recent price of $26.80.
If you would have followed this HSBC Securities's recommendation on QGEN, you would have lost 31% of your investment in 1191 days.

Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.

HSBC has refined and refocused its Global Equities organisation, creating a lean and flexible business model built to meet the needs of global issuers and investors today and in the future. Acknowledging the changing demands of clients, we have also refined our research model, moving away from traditional maintenance to focus on long term, thematic research (a two-year-plus horizon) combined with short term (zero to three months), real-time, actionable ideas both for companies and sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/11/2012 8:25 AM Sell
as of 12/31/2012
1 Week up  1.30 %
1 Month up  1.89 %
3 Months up  1.83 %
1 YTD up  1.83 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/13/2011 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy